Viridian Therapeutics, Inc./DE
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $11.2M | $131.3M | $45.9M |
| FY2021 | $16.0M | $203.7M | $42.3M |
| FY2022 | $40.0M | $435.1M | $155.6M |
| FY2023 | $48.4M | $490.4M | $102.8M |
| FY2024 | $70.8M | $742.4M | $99.6M |